Canopy Growth Corporation - Common Shares (CGC)

President Trump wants to change the regulations on cannabis. Will this change Canopy into a profitable stock?

Discover the most active stocks in Friday's session. Stay informed about the stocks that are generating the most trading volume!

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Rigetti's November plunge erased October's gains and then some. Is the quantum computing stock a buy in this sudden dip?

The U.S. government funding bill to end the shutdown included language tightening rules on hemp-derived THC products.

Tilray Brands (NASDAQ: TLRY) has once again found itself at the epicenter of market volatility, with its stock experiencing a significant dip this past week, closing near $1.34 USD as of early November 2025. This downturn comes amidst a complex tapestry of mixed signals, leaving investors and analysts grappling

Tilray Brands surged after posting stronger-than-expected quarterly results and renewed optimism around U.S. cannabis reform.

Retail investors are preparing for another busy week of earnings season with more than 1,600 companies set to report through Friday.

One marijuana industry insider says Monday's Truth Social video is a "trial balloon" testing support for marijuana legalization.

Shares of Canopy Growth are trading lower Wednesday, pulling back from a sharp rally on Monday.

President Trump's social media feed put the markets in a frenzy.

These three cannabis companies offer different ways to play an industry that's down by 80% from its peak, but showing signs of life.

U.S. markets kicked off the week quietly, but certain stocks were anything but dull. Cannabis names surged after a Trump-endorsed CBD video went viral, while biotech firm MoonLake was crushed by disastrous trial results. Meanwhile, macro tension builds with a potential U.S. government shutdown and Friday’s key jobs report looming.

President Donald Trump posted a video on Truth Social on Sunday, promoting the potential health benefits of cannabis. Cannabis stocks lit up on Monday after Trump resurrected hopes for a change in federal drug policy.

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its late-stage pipeline.

New York, NY – September 25, 2025 – Tilray Brands Inc. (NASDAQ: TLRY) saw its stock tumble by a significant -5.21% on Thursday, September 25, 2025, as investor confidence continued to erode under the weight of persistent FDA approval uncertainties and a challenging regulatory landscape. This latest decline signals growing apprehension

As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.